Heparanase and gallbladder cancer: new insights into understanding tumor growth and invasion.
Dutta
Usha
U
Poornachandra
Kuchhangi S
KS
D000230:Adenocarcinoma / Q000737:chemistry / Q000201:enzymology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D018196:Carcinoma, Adenosquamous / Q000737:chemistry / Q000201:enzymology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D049109:Cell Proliferation; D002763:Cholecystectomy; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005706:Gallbladder Neoplasms / Q000737:chemistry / Q000201:enzymology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D005966:Glucuronidase / Q000032:analysis* / Q000037:antagonists & inhibitors; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000032:analysis; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D051996:Transcription Factor RelA / Q000032:analysis; D016896:Treatment Outcome; D015854:Up-Regulation; D000099175:Heparanase
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D005966:Glucuronidase; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051996:Transcription Factor RelA; D000099175:Heparanase; C497442:HIF1A protein, human